1Abramson Cancer Center, University of Pennsylvania, 16 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA. weijing.sun@uphs.upenn.edu
Adjuvant chemotherapy for colon cancer shows promise, with FOLFOX improving outcomes for stages II and III. Capecitabine offers an alternative with fewer side effects, while pharmacogenetics may personalize treatment for stage II patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: